Compound: Lacosamide
SMILES: O=C(NCc1ccccc1)[C@H](NC(=O)C)COC
InChIKey: VPPJLAIAVCUEMN-GFCCVEGCSA-N
Synonyms: Lacosamide, 175481-36-4, Erlosamide, Vimpat, Harkoseride, SPM 927, SPM-927, (r)-lacosamide 1, MOTPOLY, Lacosamida, ADD 234037, 563KS2PQY5, SPM927, DTXSID1057666, Propanamide, 2-(acetylamino)-3-methoxy-N-(phenylmethyl)-, (2R)-, ADD243037, ADD-243037, (2R)-2-(Acetylamino)-N-benzyl-3-methoxypropanamide, (2R)-2-(Acetylamino)-3-methoxy-N-(phenylmethyl)propanamide, DTXCID2031455, (+)-(2R)-2-(acetylamino)-N-benzyl-3-methoxypropanamide, (2R)-2-acetamido-3-methoxy-N-(phenylmethyl)propanamide, lacosamidum, Motpoly XR, N benzyl AcMeOPrNH2, N-benzyl-AcMeOPrNH2, RefChem:56347, Lacosamide Oral Solution, (2R)-N-benzyl-2-acetamido-3-methoxypropanamide, N03AX18, N benzyl 2 acetamido 3 methoxypropionamide, ()-(2R)-2-(acetylamino)-N-benzyl-3-methoxypropanamide, (R)-2-acetamido-N-benzyl-3-methoxypropanamide, (2R)-2-acetamido-N-benzyl-3-methoxypropanamide, ADD 243037, ADD-234037, CHEMBL58323, Erlosamide [INN], NCGC00253740-01, N~2~-Acetyl-N-benzyl-O-methyl-D-serinamide, (R)-2-Acetylamino-N-benzyl-3-methoxy-propionamide, Lacosamide [USAN], ertosamide, harkeroside, UNII-563KS2PQY5, Lacosamide [USAN:INN:BAN], Lacosamide cv, Lacosamide?, Lacosamide CRS, SPM-929, Lacosamide racemate, MFCD08272557, Vimpat (TN), LACOSAMIDE [MI], LACOSAMIDE [INN], LACOSAMIDE [JAN], LACOSAMIDE [VANDF], LACOSAMIDE [MART.], (R)-N-Benzyl-2-acetamido-3-methoxypropionamide, LACOSAMIDE [USP-RS], LACOSAMIDE [WHO-DD], (2R)-2-acetamido-N-benzyl-3-methoxy-propanamide, (R)-2-acetamido-N-benzyl-3-methoxypropionamide., SCHEMBL35330, orb341713, Lacosamide (JAN/USAN/INN), LACOSAMIDE [EMA EPAR], GTPL7472, Lacosamide - Bio-X trade mark, DEA No. 2746, LACOSAMIDE [ORANGE BOOK], LACOSAMIDE [EP MONOGRAPH], CHEBI:135939, VPPJLAIAVCUEMN-GFCCVEGCSA-N, LACOSAMIDE [USP MONOGRAPH], Tox21_113857, BDBM50300204, Lacosamide for system suitability CRS, AKOS005146274, Lacosamide 1.0 mg/ml in Acetonitrile, CS-0529, DB06218, FL24825, KS-1227, AC-22750, BL164605, HY-13015, CAS-175481-36-4, (R)-N-benzyl-2-acetamido-3-methoxypropanamide, D07299, (R)-2-acetamido-N-benzyl-3-methoxypropionamide, (R)-N-benzyl 2-acetamido-3-methoxypropionamide, (R)-N-benzyl 2-acetamido-3-methoxypropionamide,, AB01559947-01, (2R)-2-acetylamino-N-benzyl-3-methoxypropanamide, (R)-2-Acetylamino-N-benzyl-3-methoxypropionamide, Q420077, SR-01000942286, SR-01000942286-1, BRD-K68232650-001-02-2, 2-(Acetylamino)-3-methoxy-N-(phenylmethyl)-, (2R)-, LQO
Theoretical properties:
molecular_formula: C13H18N2O3
molecular_weight: 250.29 g/mol
exact_mass: 250.13174244 g/mol
formal_charge: 0
hydrogen_bond_donor_count: 2
hydrogen_bond_acceptor_count: 3
rotatable_bond_count: 6
heavy_atom_count: 18
topological_polar_surface_area: 67.4 Å²
isotope_atom_count: 0
covalently_bonded_unit_count: 1
Physical properties:
melting_point: 140-146˚C
solubility: 10-33.3 g/L
Descriptions:
pubchem: Lacosamide is a N-acyl-amino acid.
chembl: LACOSAMIDE is a small molecule listed in the ChEMBL database and has reached clinical trial phase 4.0.
wikipedia: Lacosamide, sold under the brand name Vimpat among others, is a medication used for the treatment of Focal-onset seizures and primary generalized tonic-clonic seizures. It is used by mouth or intravenously.
It is available as a generic medication.